JPMorgan Chase Reduces $135M in Astera Labs, Inc. ($ALAB)
JPMorgan Chase reduced its stake in Astera Labs by 38.8%, selling 273,080 shares.
Key Points
- JPMorgan Chase cut its stake in Astera Labs, NasdaqGS:ALAB, by 38.8%, ending with 430,389 shares valued at $212.8 million.
- Astera Labs shares traded near $494.4 on Wednesday with a market cap of $82.8 billion and a P/E ratio of 330.8.
- Insider trades included planned sales by Bethany Mayer and Jack Lazar, while analysts have maintained varied ratings with targets ranging from $200 to $460.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
JPMorgan Chase has trimmed its holdings in Astera Labs, Inc. (NasdaqGS:ALAB) by 38.8% according to its latest filing with the SEC. The bank sold 273,080 shares, bringing its total to 430,389 shares valued at approximately $212.8 million as of the end of the reporting period.
JPMorgan Chase vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in JPMorgan Chase's Astera Labs Position
JPMorgan Chase reduced its stake in Astera Labs by 38.8%, selling off 273,080 shares. This cut brought its total holdings to 430,389 shares, which are now valued at about $212.8 million.
Other Institutional Activity in Astera Labs
FMR LLC increased its stake in Astera Labs by 194,944 shares, ending with 25,529,885 shares worth approximately $2.8 billion. BlackRock, Inc. reduced its position by 1,519,089 shares, leaving it with 11,449,769 shares valued at approximately $1.25 billion, a decrease of 11.7%. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, with 7,309,778 shares and 6,340,732 shares, respectively. Atreides Management, LP more than doubled its stake, adding 1,754,593 shares for a total of 3,365,787 shares valued at $368.9 million.
Astera Labs, Inc. Stock Up 70.8%
On Wednesday, shares of Astera Labs traded near $494.4. The company has a market capitalization of $82.8 billion and a P/E ratio of 330.8, with a forward P/E of 112.1. Its beta is 3.963, indicating higher volatility compared to the market. The stock has ranged from a 52-week low of $85.85 to a high of $499.48. The 50-day moving average is $288.50, and the 200-day moving average is $192.55.
$ALAB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Astera Labs reported revenue of about $1 billion, with a growth rate of 93.4%. The company's net margin stood at 26.7%, and it achieved a return on equity of 21.1%. Its next earnings report is expected on August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
On June 24, 2026, Bethany Mayer executed a planned sale of 686 shares at an average price of $395.04. Earlier, on June 4, Jack Lazar sold 10,000 shares at $355.17 in a planned transaction. On the same day, Craig Barratt, Michael Hurlston, and Bethany Mayer each bought 837 shares at no cost, with these transactions not being part of any planned sales.
Analysts Set New Price Targets
On June 29, 2026, UBS maintained a 'hold' rating with a $400 price target. Stifel reiterated a 'buy' rating with a $460 target on June 24. B of A Securities kept a 'hold' rating with a $450 target on June 23. Analysts' consensus suggests a 'buy' recommendation with a mean target price of $272.47 from 22 opinions.
About Astera Labs
Astera Labs, Inc. is a semiconductor company based in San Jose, California. Founded in 2017, the company designs and sells connectivity solutions for cloud and AI infrastructure. Its products include high-speed, mixed-signal connectivity platforms and COSMOS software for resource management. Led by CEO Mr. Jitendra Mohan, Astera Labs serves hyperscalers and system OEMs with operations in the U.S. and Taiwan.
Bottom Line
JPMorgan's decision to reduce its position in Astera Labs comes amid varied institutional movements and a robust stock performance. Investors keep a close watch on these filings to gauge institutional sentiment. Remember, 13F filings reflect past positions and may not indicate current holdings.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.